Caplin Point Laboratories files SEBI Takeover Regulations disclosure (Reg 31(4))

Regulatory 16 Jun 2026 · Filed / open· ✓ Verified

Caplin Point Laboratories Limited submitted a Regulation 31(4) disclosure to NSE on 16 June 2026. Regulation 31(4) requires disclosure by a target company when the acquirer crosses a 5% shareholding threshold or announces an open offer. The substance of this acquisition - including the buyer's identity, consideration, number of shares, and timeline - is not yet publicly detailed in accessible sources.

Why it mattersThe filing triggers mandatory regulatory transparency under SEBI's takeover code; counsel should obtain the full disclosure from the exchange or company to assess materiality, open offer obligations, and minority shareholder protections.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals